Hybrid U.S. Distribution Models: Filling White Space Without Replacing Existing Distributors

An established U.S. distributor can provide valuable market access, but few distributors pursue every geography, customer segment, care setting, or sales pathway with equal intensity. A hybrid distribution model allows a manufacturer to retain the benefits of an existing distributor while appointing a specialist operating partner to address opportunities that would otherwise remain uncovered.

The first step is to define the distributor’s active scope rather than relying only on broad contractual territory. A distributor may technically hold nationwide rights while concentrating its sales resources on selected regions, hospital systems, specialties, product lines, or account types. Geographic white space can therefore exist even where the agreement appears comprehensive. Similar gaps may arise in ambulatory settings, private practices, university hospitals, smaller health systems, or accounts that require more operational support than the distributor is willing to provide.

A complementary partner can also manage opportunities generated outside the distributor’s normal sales process. These may include direct referrals received by the manufacturer, established relationships with key opinion leaders, investigators, institutions, or strategic accounts, and enquiries arising from conferences, publications, digital campaigns, or clinical activity. The objective is not to divert active distributor accounts, but to create a controlled route for opportunities that the distributor did not originate or does not intend to pursue.

Some channels may require capabilities that differ from conventional distributor selling. Direct-to-consumer or direct-to-patient programs may involve patient eligibility, payment collection, prescription verification, fulfillment, returns, privacy controls, and customer support.

Veterinary products may require a separate customer base and commercial approach. Pilot channels, limited launches, employer programs, specialty pharmacies, cash-pay pathways, or new care settings may be too small, experimental, or operationally complex for the primary distributor, but still strategically important to the manufacturer.

The model works best when responsibilities are documented clearly. The parties should define protected accounts, excluded accounts, referral procedures, lead registration, pricing authority, inventory ownership, order processing, commissions, customer-service responsibilities, data access, and rules for resolving overlap. Regular account reviews can distinguish genuine channel conflict from ordinary market development and allow coverage to evolve as opportunities become clearer.

A hybrid model can therefore expand coverage without forcing an early choice between full distributor dependence and a completely direct sales organization. It preserves the distributor’s role where that partner is effective while giving the manufacturer a practical mechanism to pursue unmet demand, test new channels, support strategic relationships, and retain visibility into parts of the market that might otherwise remain inaccessible.

MDD Options can operate this complementary channel through its hybrid U.S. distribution model, managing defined accounts, referrals, pilot pathways, direct-to-patient programs, consignment activity, and specialist segments alongside an existing distributor. Because MDD Options can generate and process the sale directly, the manufacturer retains more useful customer and transaction visibility while avoiding the cost and complexity of building a separate U.S. infrastructure. Where needed, MDD Options can also help define channel boundaries, operating rules, and transition provisions before the arrangement is implemented.